Merck & Company, Inc.
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Company details
YOUFIREYOUFIREThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Company detailsA Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Company detailsA Study of SPY002-091 in Healthy Volunteers
Company detailsSubstudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
Company detailsSubstudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
Company detailsA Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults
Company detailsA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
Company detailsEffect of Maridebart Cafraglutide on the Heart's Electrical Activity
Company detailsA Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
Company detailsA Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
Company detailsSelumetinib and Olaparib in Solid Tumors
Company detailsStudy to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
Company detailsAcalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
Company detailsA Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Company detailsA Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Company detailsA Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
Company detailsA Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants
Company detailsA Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
Company detailsRadiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
Company detailsStudy Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Company detailsImpact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
Company detailsA Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
Company detailsA Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants
Company detailsTest-retest Study With [18F]FBB in Cardiac Amyloidosis
Company detailsCombination Study of Guadecitabine/ASTX727 and Pembrolizumab
Company detailsTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Company detailsA Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
Company detailsA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Company detailsComparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.
Company detailsA Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Company detailsA Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
Company detailsA Study of MK-7240 in Healthy Participants (MK-7240-009)
Company detailsA Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
Company detailsA Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults
Company detailsA Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Company detailsA Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
Company detailsA Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults
Company detailsA Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
Company detailsA Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
Company detailsA Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
Company detailsA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Company detailsA Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
Company detailsA Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
Company detailsA Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
Company detailsA Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
Company detailsA Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
Company detailsA Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
Company detailsA Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
Company detailsAnti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
Company detailsA Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Company detailsSafety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Company details
